⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8615710 | 0.70 | — | — | |
| SCHEMBL4308005 | 0.70 | — | — | |
| SCHEMBL7252042 | 0.67 | — | — | |
| SCHEMBL51846 | 0.64 | — | — | |
| SCHEMBL314229 | 0.64 | — | — | |
| Isopropyl Alcohol SCHEMBL16914724 | 0.61 | — | — | |
| Isopropyl Alcohol SCHEMBL29500440 | 0.61 | — | — | |
| Isopropyl Alcohol SCHEMBL385 | 0.61 | — | — | |
| Isopropyl Alcohol SCHEMBL29814955 | 0.61 | — | — | |
| Isopropyl Alcohol SCHEMBL890876 | 0.61 | ALDH1A1 (1.00) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 140 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021199003-A1 | OXIDIZED LIPIDS AND TREATMENT OR PREVENTION OF INFLAMMATION OR INFECTIOUS DISEASE CAUSED BY CORONAVIRUS INFECTION | VASCULAR BIOGENICS LTD. (IL) | 2021-10-07 | — | — | WO | claimed |
| US-10716800-B2 | Conjugates of a phospholipid and a drug for the treatment of inflammatory bowel disease | BEN-GURION UNIVERSITY OF THE NEGEV RESEARCH AND DEVELOPMENT AUTHORITY (IL) | 2020-07-21 | — | — | US | claimed |
| US-20190040150-A1 | Motile Sperm Domain Containing Protein 2 and Cancer | IMMUNEWALK THERAPEUTICS, INC. | 2019-02-07 | — | — | US | claimed |
| US-20180214543-A1 | Motile Sperm Domain Containing Protein 2 and Inflammation | IMMUNEWALK THERAPEUTICS, INC. | 2018-08-02 | — | — | US | claimed |
| CN-108135933-A | Protein 2 and cancer containing motile sperm structural domain | 脉管生物生长有限公司 | 2018-06-08 | — | — | CN | claimed |
| EP-3328401-A1 | MOTILE SPERM DOMAIN CONTAINING PROTEIN 2 AND CANCER | Vascular Biogenics Ltd. (IL) | 2018-06-06 | — | — | EP | claimed |
| EP-3328408-A2 | MOTILE SPERM DOMAIN CONTAINING PROTEIN 2 AND INFLAMMATION | Vascular Biogenics Ltd. (IL) | 2018-06-06 | — | — | EP | claimed |
| CN-107921084-A | Protein 2 and inflammation containing motile sperm domain | 脉管生物生长有限公司 | 2018-04-17 | — | — | CN | claimed |
| EP-3223824-A1 | OXIDIZED LIPIDS AND TREATMENT OR PREVENTION OF FIBROSIS | Vascular Biogenics Ltd. (IL) | 2017-10-04 | — | — | EP | claimed |
| WO-2017021855-A2 | MOTILE SPERM DOMAIN CONTAINING PROTEIN 2 AND INFLAMMATION | VASCULAR BIOGENICS LTD. (IL) | 2017-02-09 | — | — | WO | claimed |
| EP-1626728-A4 | OXIDIZED LIPIDS AND USES THEREOF IN THE TREATMENT OF INFLAMMATORY DISEASES AND DISORDERS | VASCULAR BIOGENICS LTD (IL) | 2009-09-02 | — | — | EP | claimed |
| WO-2009050692-A2 | PLATELET-ACTIVATING FACTOR (PAF) ANALOGS AND USES THEREOF | VASCULAR BIOGENICS LTD. (IL) | 2009-04-23 | — | — | WO | claimed |
| US-20080261865-A1 | Oxidized Lipids and Uses Thereof in the Treatment of Inflammatory Diseases and Disorders | VASCULAR BIOGENICS LTD. (IL) | 2008-10-23 | — | — | US | claimed |
| WO-2008084472-A2 | IMPROVED PROCESS FOR THE PREPARATION OF OXIDIZED PHOSPHOLIPIDS | VASCULAR BIOGENICS LTD. (IL) | 2008-07-17 | — | — | WO | claimed |
| US-20070112211-A1 | Process for the preparation of oxidized phospholipids | VASCULAR BIOGENICS LTD. (IL) | 2007-05-17 | — | — | US | claimed |
| US-20070099868-A1 | Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders | VASCULAR BIOGENICS LTD. (IL) | 2007-05-03 | — | — | US | claimed |
| EP-1773352-A2 | IMPROVED PROCESS FOR THE PREPARATION OF OXIDIZED PHOSPHOLIPIDS | Vascular Biogenics Ltd. (IL) | 2007-04-18 | — | — | EP | claimed |
| EP-1626728-A2 | OXIDIZED LIPIDS AND USES THEREOF IN THE TREATMENT OF INFLAMMATORY DISEASES AND DISORDERS | Vascular Biogenics Ltd. (IL) | 2006-02-22 | — | — | EP | claimed |
| WO-2006006161-A2 | IMPROVED PROCESS FOR THE PREPARATION OF OXIDIZED PHOSPHOLIPIDS | VASCULAR BIOGENICS LTD. (IL) | 2006-01-19 | — | — | WO | claimed |
| WO-2004106486-A2 | OXIDIZED LIPIDS AND USES THEREOF IN THE TREATMENT OF INFLAMMATORY DISEASES AND DISORDERS | VASCULAR BIOGENICS LTD. (IL) | 2004-12-09 | — | — | WO | claimed |